APA (7th ed.) Citation

Tian-tian Zhao, Ying Zhang, Cheng-qin Zhang, Ya-fei Chang, Mei-rong Cui, Yue Sun, . . . Bin-bin Wei. (2023). Combined with UPLC-Triple-TOF/MS-based plasma lipidomics and molecular pharmacology reveals the mechanisms of schisandrin against Alzheimer's disease. BMC.

Chicago Style (17th ed.) Citation

Tian-tian Zhao, et al. Combined with UPLC-Triple-TOF/MS-based Plasma Lipidomics and Molecular Pharmacology Reveals the Mechanisms of Schisandrin Against Alzheimer's Disease. BMC, 2023.

MLA (9th ed.) Citation

Tian-tian Zhao, et al. Combined with UPLC-Triple-TOF/MS-based Plasma Lipidomics and Molecular Pharmacology Reveals the Mechanisms of Schisandrin Against Alzheimer's Disease. BMC, 2023.

Warning: These citations may not always be 100% accurate.